Innovation for Health - 13 February 2020
Contact
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare

MyLife Technologies

Porous MicroNeedle Arrays for controlled dermal drug delivery

MyLife Technologies developed nanoporous MicroNeedle Arrays (npMNA) for painfree drug delivery via the skin. The nanopores of the MNAs allow for drug storage, such as peptides, small molecules and vaccines. The npMNA devices are made of ceramic material and are combined into a dermal patch.
We completed animal studies with vaccines -including an influenza challenge study- and with an Alzheimer drug (sustained release over multiple days). In Q1 2019, our first-in-human studies with a peptide formulation as a showcase will commence.
The major USPs of npMNA devices are:
• sharp needles of nanoporous, ceramic material
• compatibility with patch technology
• controlled drug release profiles

Pieter Jan Vos, CEO & co-founder

Pieter Jan Vos (1966) received his MSc in Chemistry from Leiden University, Netherlands, and graduated from ESCP Europe, School of Management, Paris, France. Pieter Jan is former Director New Business Active Pharmaceutical Ingredients at Diosynth / Organon, Oss, the Netherlands. He subsequently founded Amspar, a company that focuses on global licensing of generic pharmaceuticals. Till date, 25 international licensing agreements have been established. Pieter Jan co-founded MyLife Technologies in 2012. He is experienced in innovation and project management in multidisciplinary and multinational teams. Pieter Jan successfully attracted national and European grants and investments from informal investors and regional investor Uniiq.
Reboocon wins start-up pitch contest!

Reboocon has won the AXON Innovation for Health Award 2019 for the best start-up pitch at the sixth edition of Innovation for Health and the third edition of Global Investor Forum in WTC Rotterdam on 14 February 2019. Reboocon competed against River Biomedics in the plenary afternoon programme and at the end received the majority vote from the audience as the best start-up.
Read press release

Join the VIP CEO-Investor dinner!
Aftermovie Innovation for Health

The aftermovie of Innovation for Health 2019 is online now, including highlights of the programme and exhibition.
Watch the aftermovie and experience Innovation for Health 2019 in only 2 minutes!

Looking forward welcoming you to the next edition of Innovation for Health in 2020! (date will be announced soon)
Watch the aftermovie

Teaser Innovation for Health 2019
Photo impression 2019

Did you enjoy Innovation for Health & Global Investor Forum 2019? 

Take a look at our photo impression  and you will experience the event of 14 February all over again!
Go to Photo Impression

Join the Design Expo!
Sponsors & Partners 2019
Main partner
Health~Holland
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
MSD
Platinum sponsor
Janssen Diagnostics - Janssen
Gold sponsor
Medical Delta
Silver sponsor
NLC The Healthtec Venture Builder
Sponsor
Kempen
Award sponsor
AXON Lawyers
Award sponsor
Genmab
Partner
Vereniging Innovatieve Geneesmiddelen
Partner
Global Investor Forum
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.